Literature DB >> 12372295

Identification of TOR signaling complexes: more TORC for the cell growth engine.

Robert T Abraham1.   

Abstract

The Target of Rapamycin (TOR) proteins function in signaling pathways that promote protein synthesis and cell growth. In yeast, TOR signaling is regulated by nutrient availability, whereas in metazoan cells TOR activities may be controlled by both nutrients and growth factors. The recent identification of novel TOR-interacting proteins has provided crucial insights into TOR regulation and function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372295     DOI: 10.1016/s0092-8674(02)01009-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  29 in total

1.  Chromatin-mediated regulation of nucleolar structure and RNA Pol I localization by TOR.

Authors:  Chi Kwan Tsang; Paula G Bertram; Wandong Ai; Ryan Drenan; X F Steven Zheng
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

2.  S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Authors:  Mario Pende; Sung Hee Um; Virginie Mieulet; Melanie Sticker; Valerie L Goss; Jurgen Mestan; Matthias Mueller; Stefano Fumagalli; Sara C Kozma; George Thomas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Arabidopsis TARGET OF RAPAMYCIN interacts with RAPTOR, which regulates the activity of S6 kinase in response to osmotic stress signals.

Authors:  Magdy M Mahfouz; Sunghan Kim; Ashton J Delauney; Desh Pal S Verma
Journal:  Plant Cell       Date:  2005-12-23       Impact factor: 11.277

4.  Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma.

Authors:  Heather Francois-Vaughan; Adeola O Adebayo; Kate E Brilliant; Nicola M A Parry; Philip A Gruppuso; Jennifer A Sanders
Journal:  Carcinogenesis       Date:  2016-02-10       Impact factor: 4.944

5.  The pleckstrin homology domain proteins Slm1 and Slm2 are required for actin cytoskeleton organization in yeast and bind phosphatidylinositol-4,5-bisphosphate and TORC2.

Authors:  Maria Fadri; Alexes Daquinag; Shimei Wang; Tao Xue; Jeannette Kunz
Journal:  Mol Biol Cell       Date:  2005-02-02       Impact factor: 4.138

6.  Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.

Authors:  Yann-Gaël Gangloff; Matthias Mueller; Stephen G Dann; Petr Svoboda; Melanie Sticker; Jean-Francois Spetz; Sung Hee Um; Eric J Brown; Silvia Cereghini; George Thomas; Sara C Kozma
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR).

Authors:  Rosa H Jimenez; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Nicola Neretti; Jennifer A Sanders; John Sedivy; Philip A Gruppuso
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

8.  Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung.

Authors:  J Matthew McDonald; Christopher E Pelloski; Alicia Ledoux; Menghong Sun; Gabriela Raso; Ritsuko Komaki; Ignacio I Wistuba; B Nebiyou Bekele; Ken Aldape
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

9.  Role of the steroid receptor coactivator SRC-3 in cell growth.

Authors:  Ge Zhou; Yoshihiro Hashimoto; Inseok Kwak; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 10.  Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Drug Resist Updat       Date:  2008-04-28       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.